Spots Global Cancer Trial Database for pancreatic neoplasms
Every month we try and update this database with for pancreatic neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis | NCT03152487 | Pancreatic Carc... Pancreatic Aden... Pancreatic Neop... Pancreatic Canc... Pancreatic Canc... | Celiac Plexus N... Radiofrequency ... | 19 Years - | AdventHealth | |
| Combination With Gemcitabine in Advanced Pancreatic Cancer | NCT01251640 | Pancreatic Neop... | BAY86-9766+Gemc... | 18 Years - 99 Years | Bayer | |
| A Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors | NCT05571839 | Cutaneous Melan... Non-small Cell ... Colorectal Neop... Pancreatic Neop... Mesothelioma | SGN-BB228 | 18 Years - | Seagen Inc. | |
| Circulating Epigenetics in Pancreatic Surgery | NCT04947696 | Pancreatic Neop... | Blood sampling | 18 Years - | Rigshospitalet, Denmark | |
| Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms | NCT03435770 | Pancreatic Canc... Pancreatic Neop... Pancreatic Aden... Pancreatic Neur... Pancreatic Duct... | EUSRA RFA needl... | 21 Years - 99 Years | Singapore General Hospital | |
| Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia | NCT02267707 | Pancreatic Neop... Cholestasis | nab-paclitaxel Gemcitabine | 18 Years - | Celgene | |
| Comparison of Two Types of Biopsy Needles for EUS-FNB in Solid Pancreatobiliary Mass Lesions | NCT04975620 | Pancreatic Neop... | Fine needle bio... | 18 Years - | University of Tehran | |
| Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca | NCT01555489 | Stage IV Pancre... | Ascorbic Acid | 18 Years - | Thomas Jefferson University | |
| Project Survival-Prospective Biomarker Discovery | NCT02781012 | Pancreatic Neop... Pancreatic Canc... Pancreatitis Pancreatic Aden... Metastatic Panc... | 18 Years - | Pancreatic Cancer Research Team | ||
| A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer. | NCT05493995 | Pancreatic Neop... | Penpulimab Anlotinib Nab paclitaxel Gemcitabine | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma | NCT01161186 | Pancreatic Neop... Pancreatic Canc... Adenocarcinoma | nab-paclitaxel,... | 18 Years - | University of California, San Francisco | |
| Pancreatic and Periampullary Tumors in Greenland Inuit | NCT05595811 | Pancreatic Neop... Periampullary N... | outcome followi... | 41 Years - 79 Years | Rigshospitalet, Denmark | |
| Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies | NCT01677559 | Adenocarcinoma Pancreatic Neop... | MLN8237 nab-Paclitaxel | 18 Years - | Washington University School of Medicine | |
| A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy | NCT00359320 | Pancreatic Neop... Biliary Tract N... Pancreatitis, C... Duodenal Neopla... | pancreaticojeju... | 18 Years - | Thomas Jefferson University | |
| Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder | NCT05512377 | Pancreatic Neop... Solid Tumors Biliary Tract C... Lung Neoplasms Bladder Cancer | brigimadlin | 18 Years - | Boehringer Ingelheim | |
| A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma | NCT02993731 | Carcinoma, Panc... | Napabucasin Nab-paclitaxel Gemcitabine | 18 Years - | Sumitomo Pharma America, Inc. | |
| Efficacy of the Transversus Abdominis Plane Block on Analgesia After Cephalic Duodeno-pancreatectomy | NCT05546970 | Pancreatic Neop... | 18 Years - | University Hospital, Strasbourg, France | ||
| Feasibility of Using Ultrasound to Track Respiration Motion | NCT02173353 | Pancreatic Neop... | Ultrasound | 18 Years - | Medical College of Wisconsin | |
| CT Pancreas Perfusion | NCT00588367 | Pancreatic Duct... Chronic Pancrea... Autoimmune Panc... | Mayo Interactiv... | 18 Years - | Mayo Clinic | |
| Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) | NCT02758587 | Carcinoma, Non-... Mesothelioma Pancreatic Neop... | Defactinib Pembrolizumab | 18 Years - | NHS Greater Glasgow and Clyde | |
| FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma | NCT01383538 | Pancreatic Canc... Adenocarcinoma Pancreatic Neop... | FOLFIRINOX, IPI... | 18 Years - | University of California, San Francisco | |
| Intermittent Suction Technique in the Diagnosis of Pancreatic Solid Lesions | NCT03829748 | Pancreatic Canc... Pancreatic Neop... | Intermittent as... | 18 Years - | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | |
| Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter | NCT00160836 | Pancreatic Neop... Cholangiocarcin... Pancreatitis | Tissue sampling... | 18 Years - | University Hospital, Geneva | |
| Pancreatic Anastomosis After Duodenopancreatectomy | NCT04462354 | Pancreatic Anas... Pancreatic Neop... | Blumgart Anasto... Pancreatogastri... | 18 Years - | Fundación para la Investigación del Hospital Clínico de Valencia | |
| Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer | NCT04289792 | Pancreatic Neop... | nab-Paclitaxel+... split-course SB... | 18 Years - 70 Years | Fujian Medical University Union Hospital | |
| Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer | NCT00242190 | Pancreatic Neop... | oxaliplatin gemcitabine radiation thera... | 18 Years - | University of Michigan Rogel Cancer Center | |
| A Research Trial of High Dose Vitamin C and Chemotherapy for Metastatic Pancreatic Cancer | NCT01049880 | Pancreatic Neop... | Gemcitabine wit... | 18 Years - | University of Iowa | |
| Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer | NCT00487851 | Pancreatic Neop... Biliary Tract N... Duodenal Neopla... | surgery endoscopic stra... | - | Karolinska Institutet | |
| Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer | NCT01419483 | Pancreatic Neop... | Ketogenic diet | 18 Years - | University of Iowa | |
| A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma | NCT01166490 | Gastric Neoplas... Pancreatic Neop... | ASG-5ME | 18 Years - | Seagen Inc. | |
| LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS) | NCT04889404 | Pancreatic Neop... | - | AstraZeneca | ||
| 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients | NCT01832116 | Ovarian Neoplas... Ovarian Disease... Adnexal Disease... Pancreatic Neop... Digestive Syste... Digestive Syste... Pancreatic Dise... | 89Zr-MMOT0530A | 18 Years - | University Medical Center Groningen | |
| Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic Cancer | NCT03199144 | Pancreatic Neop... | Chemotherapy Stereotactic ra... Surgery | 18 Years - | Centre Francois Baclesse, Luxembourg | |
| A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma | NCT01166490 | Gastric Neoplas... Pancreatic Neop... | ASG-5ME | 18 Years - | Seagen Inc. | |
| A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer | NCT05451849 | Mesothelioma Mesotheliomas P... Mesothelioma, M... Mesothelioma Pe... Ovarian Cancer Ovarian Serous ... Pancreatic Canc... Pancreatic Aden... Colorectal Canc... Triple Negative... TNBC - Triple-N... Ovarian Adenoca... Pancreatic Neop... Colorectal Neop... Ovarian Neoplas... Cholangiocarcin... Non Small Cell ... | TC-510 Fludarabine Cyclophosphamid... | 18 Years - | TCR2 Therapeutics | |
| Circulating Epigenetics in Pancreatic Surgery | NCT04947696 | Pancreatic Neop... | Blood sampling | 18 Years - | Rigshospitalet, Denmark | |
| Analgesia and Pancreatic Cancer Surgery | NCT01929915 | Pancreatic Neop... | Epidural patien... Intravenous pat... | 20 Years - 85 Years | National Taiwan University Hospital | |
| Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer | NCT05218889 | Pancreatic Canc... PDAC - Pancreat... Pancreas Cancer Pancreatic Neop... | surufatinib + c... nab-paclitaxel ... | 18 Years - 75 Years | Chinese PLA General Hospital | |
| Comparison Between Olympus EZ Shot 3Plus 19G and EZ Shot 2 19G in EUS-guided FNB of Solid Pancreatic Masses | NCT02909530 | Pancreatic Neop... | EUS-FNB with EZ... EUS-FNB with EZ... | 18 Years - | University of Ulm | |
| The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery | NCT02381249 | Esophageal Neop... Stomach Neoplas... Weight Loss Malnutrition Pancreatic Neop... Duodenal Neopla... | Octreotide Placebo | 18 Years - 100 Years | St. James's Hospital, Ireland | |
| Greater Omentum Binding to the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy | NCT03752086 | Pancreatic Fist... Pancreatic Neop... | greater omentum... Pancreatic stum... | 18 Years - 75 Years | Tongji Hospital | |
| Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma | NCT01950572 | Mesothelioma Thymoma Pancreatic Neop... Biliary Tract N... Stomach Neoplas... | 2 Years - | National Institutes of Health Clinical Center (CC) | ||
| A Deep Learning Radiomics Model for Predicting Occult Peritoneal Metastases of Pancreatic Adenocarcinoma | NCT06336694 | Pancreatic Neop... | surgery or diag... | 18 Years - | First Affiliated Hospital, Sun Yat-Sen University | |
| SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma | NCT01362790 | Mesothelioma Adenocarcinoma ... Pancreatic Neop... | Pentostatin Cyclophosphamid... SS1(dsFv)PE38 -... SS1(dsFv)PE38 -... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Surgery | NCT03838029 | Pancreatic Neop... | Propranolol and... Placebo | 20 Years - 80 Years | Assaf-Harofeh Medical Center | |
| Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols | NCT04299880 | Oncology | Napabucasin Nab-paclitaxel Gemcitabine Nivolumab Paclitaxel Irinotecan Leucovorin 5Fluorouracil Bevacizumab | 18 Years - | Sumitomo Pharma America, Inc. | |
| Comparation Between Needles for EUS-guided Sampling of Solid Pancreatic Lesions | NCT04877340 | Pancreatic Neop... | needle punction | 18 Years - | Instituto do Cancer do Estado de São Paulo | |
| Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma | NCT01950572 | Mesothelioma Thymoma Pancreatic Neop... Biliary Tract N... Stomach Neoplas... | 2 Years - | National Institutes of Health Clinical Center (CC) | ||
| Evaluation of Killing Activity of Expanded Natural Killer Cells From Blood in Patients With Pancreatic Cancer | NCT03665571 | Pancreatic Neop... | Receptor specif... | 20 Years - 80 Years | Asan Medical Center | |
| Institut Paoli-Calmettes Pancreatic Neoplasms Database | NCT02869581 | Pancreatic Neop... | Data collection | 18 Years - | Institut Paoli-Calmettes | |
| Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer | NCT00005648 | Pancreatic Neop... | Gemcitabine wit... Gemcitabine wit... | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer | NCT00529113 | Pancreatic Neop... Pancreatic Canc... | Bardoxolone met... Bardoxolone met... Bardoxolone met... Bardoxolone met... Bardoxolone met... Bardoxolone met... Bardoxolone met... Gemcitabine Placebo Bardoxolone met... | 18 Years - | Biogen | |
| Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery | NCT00833859 | Pancreatic Neop... | GTX (gemcitabin... stereotactic bo... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Analgesia and Pancreatic Cancer Surgery | NCT01929915 | Pancreatic Neop... | Epidural patien... Intravenous pat... | 20 Years - 85 Years | National Taiwan University Hospital | |
| The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer | NCT00268840 | Pancreatic Neop... Biliary Tract N... | Docetaxel Gemcitabine | 18 Years - 60 Years | ARCAGY/ GINECO GROUP | |
| Role of EUS in Detection of Liver Metastasis | NCT04509492 | Liver Metastase... Pancreatic Neop... | Endoscopic ultr... | 12 Years - 75 Years | Cairo University | |
| Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols | NCT04299880 | Oncology | Napabucasin Nab-paclitaxel Gemcitabine Nivolumab Paclitaxel Irinotecan Leucovorin 5Fluorouracil Bevacizumab | 18 Years - | Sumitomo Pharma America, Inc. | |
| Single-centre Propensity Score-matched Comparison of Laparoscopic Versus Open Pancreatoduodenectomy | NCT05110573 | Pancreatic Neop... | pancreatoduoden... | 18 Years - | General Hospital Groeninge | |
| Multivisceral Resection in Distal Pancreatectomy | NCT04317352 | Pancreatic Neop... Surgical Proced... | MVR | 18 Years - | Universidad de Extremadura | |
| Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples | NCT05737953 | Pancreatic Neop... DNA Methylation Proteome | cfDNA methylati... | 18 Years - | Changhai Hospital | |
| Diagnostic Yield of 20-gauge Procore Needle for EUS-guided FNA Biopsy in Solid Pancreatic Lesions | NCT02920944 | Pancreatic Neop... | EUS-FNB with 20... EUS-FNB with 22... | 20 Years - | Seoul St. Mary's Hospital | |
| Brown Adipose Tissue Activity and Energy Metabolism in Cachexia | NCT02500004 | Cachexia Neoplasms Pulmonary Disea... Pancreatic Neop... | 18F-FDG PET-MRI... DXA scanning Abdominal subcu... Blood sampling Indirect calori... Accelerometry Double-labeled ... | 30 Years - | Maastricht University Medical Center | |
| Change of Treatment Landscape and Survival in Metastatic Pancreatic Cancer After Nal-IRI in Republic of Korea | NCT05587387 | Pancreatic Neop... | 18 Years - | Yonsei University | ||
| Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas | NCT00220649 | Pancreatic Neop... | gemcitabine; ir... | 18 Years - | St. Luke's-Roosevelt Hospital Center | |
| Rapid On-Site Evaluation (ROSE) by Endosonographer: for Whom, When and by Whom? | NCT04002778 | Pancreatic Neop... | Fine needle asp... Rapid on-site e... | 18 Years - | Universidade Federal do Rio de Janeiro | |
| The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer | NCT00268840 | Pancreatic Neop... Biliary Tract N... | Docetaxel Gemcitabine | 18 Years - 60 Years | ARCAGY/ GINECO GROUP | |
| A Study of LY2880070 in Participants With Advanced or Metastatic Cancer | NCT02632448 | Solid Tumors Colorectal Canc... Breast Cancer Ovarian Cancer Colon Cancer Rectal Cancer Neoplasms Endometrial Can... Soft Tissue Sar... Triple Negative... Pancreas Cancer Pancreatic Canc... | LY2880070 Gemcitabine | 18 Years - | Esperas Pharma Inc. | |
| M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas | NCT03451773 | Cancer of Pancr... Pancreas Cancer Pancreatic Aden... Pancreatic Canc... Pancreatic Neop... | M7824 Gemcitabine | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| The Detection of CTCs in Patients With Pancreatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment. | NCT02406846 | Neoplastic Cell... | Flow cytometry ... RT-PCR | 18 Years - 75 Years | Fuda Cancer Hospital, Guangzhou | |
| A Research Trial of High Dose Vitamin C and Chemotherapy for Metastatic Pancreatic Cancer | NCT01049880 | Pancreatic Neop... | Gemcitabine wit... | 18 Years - | University of Iowa | |
| Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy | NCT00363051 | Islet Cell Carc... Neuroendocrine ... Neuroendocrine ... Pancreatic Neop... | Everolimus 10 m... Octreotide Depo... | 18 Years - | Novartis | |
| Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms | NCT03435770 | Pancreatic Canc... Pancreatic Neop... Pancreatic Aden... Pancreatic Neur... Pancreatic Duct... | EUSRA RFA needl... | 21 Years - 99 Years | Singapore General Hospital | |
| Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas | NCT00116389 | Pancreatic Canc... Neoplasm Metast... Adenocarcinoma | talabostat mesy... gemcitabine | 18 Years - | Point Therapeutics | |
| Contrast-enhanced Diffusion-weighted MRI to Detect Liver Metastases in Patients With Pancreatic Cancer | NCT03469726 | Pancreatic Neop... | Contrast-enhanc... | 18 Years - | Radboud University Medical Center | |
| Early (4 Days) Versus Standard Drainage of the Abdominal Cavity After Pancreaticoduodenectomy | NCT01368094 | Pancreatic Dise... Pancreatic Neop... | Drain removal a... Standard drain ... | 18 Years - | Centre Hospitalier Universitaire, Amiens | |
| Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas | NCT01088815 | Metastatic Panc... | Gemcitabine, na... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors | NCT00841191 | Ovarian Neoplas... Pancreatic Neop... Colorectal Neop... Head and Neck N... Lung Neoplasms | CNTO 328; Anti-... CNTO 328; Anti-... CNTO 328; Anti-... CNTO 328; Anti-... CNTO 328; Anti-... CNTO 328; Anti-... CNTO 328; Anti-... | 18 Years - | Centocor, Inc. | |
| Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient | NCT02338752 | Pancreatic Neop... | MV Standard Treatm... | 18 Years - 18 Years | Fuda Cancer Hospital, Guangzhou | |
| Brown Adipose Tissue Activity and Energy Metabolism in Cachexia | NCT02500004 | Cachexia Neoplasms Pulmonary Disea... Pancreatic Neop... | 18F-FDG PET-MRI... DXA scanning Abdominal subcu... Blood sampling Indirect calori... Accelerometry Double-labeled ... | 30 Years - | Maastricht University Medical Center | |
| Application of ctDNA in Evaluation of Neoadjuvant Chemotherapy Efficacy and Exploration of Chemoresistance Mechanisms in Pancreatic Cancer | NCT05848154 | Patients With N... Evaluation of T... | ctDNA detection | 18 Years - 75 Years | Shanghai Zhongshan Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
